126954-66-3 Usage
General Description
2,5-Dichloronicotinonitrile is a chemical compound that is also known as 2,5-dichloropyridine-4-carbonitrile. It is a white to light yellow solid that is primarily used as an intermediate in the synthesis of agricultural chemicals such as insecticides and herbicides. 2,5-Dichloronicotinonitrile is also used in pharmaceutical research and other organic synthesis processes. It is important to handle 2,5-Dichloronicotinonitrile with caution as it is toxic if ingested or inhaled, and can cause severe skin and eye irritation. Additionally, it may pose a risk to the aquatic environment and should be handled and disposed of in accordance with local regulations and guidelines.
Check Digit Verification of cas no
The CAS Registry Mumber 126954-66-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,9,5 and 4 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 126954-66:
(8*1)+(7*2)+(6*6)+(5*9)+(4*5)+(3*4)+(2*6)+(1*6)=153
153 % 10 = 3
So 126954-66-3 is a valid CAS Registry Number.
InChI:InChI=1S/C6H2Cl2N2/c7-5-1-4(2-9)6(8)10-3-5/h1,3H
126954-66-3Relevant articles and documents
Influenza virus replication inhibitor and application thereof
-
Paragraph 0475; 0507; 0508, (2018/07/30)
The invention relates to an influenza virus replication inhibitor and application thereof, and particularly relates to a compound serving as an influenza virus replication inhibitor, a preparation method thereof, a pharmaceutical composition containing the compound, and application of the compound and the pharmaceutical composition to influenza treatment.
Influenza virus replication inhibitor and application thereof
-
Paragraph 0607; 0622-0624, (2018/11/22)
The invention provides a type of compounds serving as an influenza virus replication inhibitor, a preparation method of the compounds, a pharmaceutical composition comprising the compounds, and application of the compounds and the pharmaceutical composition thereof in treatment of influenza.
